| Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases T Masoodi, S Siraj, AK Siraj, S Azam, Z Qadri, SK Parvathareddy, ... British journal of cancer 122 (8), 1219-1230, 2020 | 64 | 2020 |
| Telomerase reverse transcriptase mutations are independent predictor of disease‐free survival in M iddle E astern papillary thyroid cancer R Bu, AK Siraj, SP Divya, Y Kong, SK Parvathareddy, M Al‐Rasheed, ... International journal of cancer 142 (10), 2028-2039, 2018 | 61 | 2018 |
| Whole-exome sequencing of matched primary and metastatic papillary thyroid cancer T Masoodi, AK Siraj, S Siraj, S Azam, Z Qadri, WN Albalawy, ... Thyroid 30 (1), 42-56, 2020 | 31 | 2020 |
| Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation SK Parvathareddy, AK Siraj, IA Al-Badawi, A Tulbah, F Al-Dayel, ... Scientific Reports 11 (1), 3750, 2021 | 30 | 2021 |
| The utility of ROSE (rapid on-site evaluation) in endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA): Is the picture rosy? V Mallya, SP Kumar, P Meganathan, S Shivkumar, R Mehta Journal of Cytology/Indian Academy of Cytologists 32 (4), 230, 2015 | 30 | 2015 |
| Expanding the spectrum of germline variants in cancer AK Siraj, T Masoodi, R Bu, SK Parvathareddy, IA Al-Badawi, N Al-Sanea, ... Human genetics 136, 1431-1444, 2017 | 28 | 2017 |
| TGFβ-induced SMAD4-dependent apoptosis proceeded by EMT in CRC AK Siraj, P Pratheeshkumar, SP Divya, SK Parvathareddy, R Bu, ... Molecular cancer therapeutics 18 (7), 1312-1322, 2019 | 26 | 2019 |
| Evolution and impact of subclonal mutations in papillary thyroid cancer T Masoodi, AK Siraj, S Siraj, S Azam, Z Qadri, SK Parvathareddy, ... The American Journal of Human Genetics 105 (5), 959-973, 2019 | 21 | 2019 |
| FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells P Pratheeshkumar, SP Divya, SK Parvathareddy, NM Alhoshani, ... Oncotarget 9 (3), 3590, 2018 | 21 | 2018 |
| Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma AK Siraj, P Pratheeshkumar, SK Parvathareddy, R Bu, T Masoodi, K Iqbal, ... European Journal of Cancer 117, 133-144, 2019 | 20 | 2019 |
| APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapy AK Siraj, SK Parvathareddy, P Pratheeshkumar, SP Divya, SO Ahmed, ... Biomedicine & Pharmacotherapy 121, 109572, 2020 | 18 | 2020 |
| PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation AK Siraj, SK Parvathareddy, P Pratheeshkumar, SP Divya, SS Al-Sobhi, ... Cancers 13 (3), 555, 2021 | 17 | 2021 |
| On the Kheinjua Formation of Semri Group (Lower Vindhyan) Newari area, Mirzapur District, UP S Kumar | 17 | 1978 |
| Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region AK Siraj, SK Parvathareddy, R Bu, K Iqbal, S Siraj, T Masoodi, ... Cancer Cell International 19 (1), 1-9, 2019 | 16 | 2019 |
| FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer AK Siraj, P Pratheeshkumar, SK Parvathareddy, Z Qadri, S Thangavel, ... Oncotarget 9 (25), 17466, 2018 | 16 | 2018 |
| Annual hazard rate of recurrence in Middle Eastern papillary thyroid cancer over a long-term follow-up AK Siraj, SK Parvathareddy, Z Qadri, K Siddiqui, SS Al-Sobhi, F Al-Dayel, ... Cancers 12 (12), 3624, 2020 | 15 | 2020 |
| Prevalence, spectrum, and founder effect of BRCA1 and BRCA2 mutations in epithelial ovarian cancer from the Middle East AK Siraj, R Bu, K Iqbal, N Siraj, W Al‐Haqawi, IA Al‐Badawi, ... Human mutation 40 (6), 729-733, 2019 | 14 | 2019 |
| PD-L1 protein expression in middle eastern breast cancer predicts favorable outcome in triple-negative breast cancer SK Parvathareddy, AK Siraj, SO Ahmed, LO Ghazwani, SM Aldughaither, ... Cells 10 (2), 229, 2021 | 13 | 2021 |
| Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population AK Siraj, R Bu, K Iqbal, SK Parvathareddy, N Siraj, S Siraj, MRF Diaz, ... Genomics 112 (2), 1746-1753, 2020 | 13 | 2020 |
| Recurrent Somatic MAP2K1 Mutations in Papillary Thyroid Cancer and Colorectal Cancer R Bu, AK Siraj, T Masoodi, SK Parvathareddy, K Iqbal, M Al-Rasheed, ... Frontiers in Oncology 11, 670423, 2021 | 12 | 2021 |
